DexCom, Inc. (DXCM) Stock Price Today
Alphabet downgraded to Hold amid AI delays and rising competition from Microsoft
Investment firm UBS downgraded Alphabet Inc. stock to "Hold" due to delays in its AI model Gemini 3.5 Pro and increased competition from Microsoft, which reported strong AI and cloud growth. Alphabet is also under investigation for potential securiti...
Strategic acquisitions and strong contracts drive major gains in top stocks and leveraged ETFs.
Top stock gainers surged due to strategic acquisitions and successful project deliveries. PN Smart Energy's shares jumped 120.80% after acquiring full equity in Nanjing Cesun Power, advancing its global power producer ambitions. T3 Defense rose 69.22...
Regional banks, telehealth, and inverse ETFs plunge on earnings misses, legal probes, and weak outlooks
Regional banking stocks like Coastal Financial and GBank Financial dropped sharply due to poor Q2 earnings and a legal investigation. Teladoc Health's shares fell despite beating earnings estimates, as it lowered its 2026 outlook. Inverse leveraged E...
UBS nears Credit Suisse integration amid strong Q2 but cautious outlook with new $3B buyback.
UBS is close to completing its integration of Credit Suisse, marking a major strategic step. The bank reported strong Q2 results with net profit rising to $2.80 billion and revenues up 13.1% to $13.70 billion. Despite this, Morgan Stanley kept an Und...
Inno Holdings resumes Nasdaq trading after a halt with no new material developments.
Inno Holdings Inc. announced that its common stock will resume trading on The Nasdaq Capital Market starting July 31, 2026, after a trading halt was imposed on June 12, 2026, due to unusual trading activities. The company stated it is unaware of any ...
Carvana's Q2 results show shrinking profits and margins, prompting a downgrade to neutral.
Carvana reported Q2 earnings that beat expectations but revealed shrinking gross profit per unit and declining adjusted EBITDA margins. The company’s full-year 2026 profit forecast disappointed investors, projecting adjusted EBITDA between $2.70 bill...
FDA advisory panel finds Replimune's RP1 effective and meaningful for advanced melanoma treatment
The FDA's Cellular, Tissue, and Gene Therapies Advisory Committee voted 10 to 3 that the efficacy results from Replimune's IGNYTE study on RP1 combined with nivolumab for advanced melanoma are evaluable and clinically meaningful. This supports the Bi...
XAI Floating Rate Trust faces possible liquidation amid shareholder disputes over advisory plans.
The XAI Floating Rate & Alternative Income Trust (XFLT) is facing the possibility of liquidation at full net asset value if its board fails to secure 67% shareholder approval for a permanent sub-advisor plan. Currently, XFLT trades at about 80% of it...
Shinhan Bank partners with StoneX Payments for advanced cross-border payments in 140+ currencies.
Shinhan Bank, South Korea's second-largest bank, has partnered with StoneX Payments to enhance its cross-border payment and foreign exchange services. This partnership provides Shinhan Bank's clients access to StoneX's institutional-grade platform, s...
America's Car-Mart faces securities fraud probe after financial disclosure issues hurt stock.
America's Car-Mart delayed its annual report in July 2025 due to needed disclosures about loan modifications for financially troubled borrowers. Subsequent revelations showed prior financial statements were unreliable, causing the stock to drop signi...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.